Research Process and Methodology

Research Scope

Key Findings

Brazil has the most expensive healthcare market across BRICS

Impact of Ageing & Middle Class Population Demographics

Increasing diseases burden is a common trend across Brazil

Plethora of different healthcare regulations present in Brazil

Plethora of different healthcare regulations present in Brazil

Three key government programs have initiated in Brazil

Comparative assessment of Brazilian payors and providers

Aging population is the biggest driver for Brazil to improve healthcare infrastructure

Medical tourism holds great potential in Brazil

Critical need for more investment to bridge infrastructure demands

Brazil has sixth largest pharmaceutical & biotechnology market globally

LATAM’s biggest medical device market present in Brazil

Billion dollar medical imaging market in Brazil

Brazil’s diagnostics market is getting more consolidated

Healthcare IT is more prominent in private hospitals

Slow growth in rate of acquisition and mergers

Key Takeaways

High mortality rates due to short life expectancies present in Russia

Affordability for healthcare services are rather low across Russia

Ageing population is resulting in a greater disease burden

Need for more government involvement to improve healthcare availability

Majority of hospitals in Russia are state owned

Corruption and bureaucracy hinders growth of healthcare market

Greater innovations being developed in Russia for healthcare applications

Political conditions result in healthcare market growth hindrance

Russia is a hot bed for pharmaceutical and biotechnology research

Most medical devices are imported in Russia

Twenty percent of private hospitals are adopting Healthcare IT solutions

Recent mergers and acquisitions could drive the Russian healthcare space

Key Takeaways

World’s second largest population needs to address key healthcare issues

Indians lack adequate health insurance coverage

Disease Burden

Stringency in healthcare regulations still lacking across India

Stringency in healthcare regulations still lacking across India

Steady growth in private healthcare sector across India

Socio-economic inequality results not addressed by healthcare availability

Need based regulation initiatives driving the healthcare market

Growing population turns into a major burden for managing disease outbreak

India is the third largest market when considering volumetric consumption of medication

Close to eighty percent of the medical imaging market is held by international participants

Greater adoption of automation across medical diagnostics market in India

Government of India has introduced the National E-governance plan

2015 a big year for mergers and acquisitions cross the India healthcare market

Key Takeaways

China is also becoming a growing hub for healthcare research and development

Urbanization leads to prevalence of chronic lifestyle diseases in China

Major increase in disease burden present in China

Critical need for greater stringency in healthcare regulations across China

Majority of the Chinese population is covered by some form of medical insurance

Urbanization in China increased pressure for more healthcare solutions

Ageing population increasing, the demand for healthcare services

Hospitals do not have a well structured environment to provide critical care

High levels of research and development in Chinese pharmaceutical and biotechnology companies

Multiple medical imaging manufacturers provide infrastructure to hospitals in China

China’s diagnostics market is the fastest growing market in Asia

Healthcare IT adoption has been present for a decade in China

Slow growth trends in mergers and acquisitions across the healthcare industry in China

Key Takeaways

Key Patents

Key Patents (continued)

Key Patents (continued)

Key Patents (continued)

Key Patents (continued)

Contacts

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy